Linde Jacobs paced back and forth across her bedroom, eyeing the open laptop on the dresser and willing the doctor to appear. Her husband was dropping off their older daughter at school. Their younger daughter was downstairs, occupied by a screen. Linde wanted to be alone when she learned whether she carried the family curse.
People with severe, treatment-resistant depression who received a nerve-stimulating therapy showed significant improvement in depressive symptoms, quality of life and ability to complete everyday tasks after a year, according to the results of a national, multicenter clinical trial led by Washington University School of Medicine in St. Louis. The findings are published Dec. 18 in a […]
Researchers at Washington University School of Medicine in St. Louis have been awarded $7.5 million from the National Institutes of Health (NIH) to investigate a form of dementia caused by cerebral small vessel disease, the second-leading cause of dementia after Alzheimer’s disease.
In this episode, Dr. Bucelli shares his wealth of knowledge on neuromuscular neurology, exploring topics such as:
Alzheimer’s disease and frontotemporal dementia are devastating disorders that emerge following the buildup of misfolded proteins in the brain. The newest generation of Alzheimer’s therapeutics targets accumulations of the protein amyloid beta with engineered antibodies, but the results have been underwhelming, with some adverse effects, not to mention using engineered antibodies can be prohibitively expensive.
Miranda Orr, PhD, associate professor of Neurology, is co-director of the Tracy Family Stable Isotope Labeling Quantitation (SILQ) Center. Orr came to Washington University School of Medicine in St. Louis from Wake Forest University School of Medicine in Winston-Salem, North Carolina, where she was an associate professor in the Section of Gerontology and Geriatric Medicine. […]
In a testament to the quality and national competitiveness of biomedical research at Washington University School of Medicine in St. Louis, the school secured $683 million in research funding from the National Institutes of Health (NIH) in federal fiscal year 2024 – a record high for WashU Medicine and an affirmation of its leadership in […]
More than half a century after the U.S. government deemed psychedelic drugs to be of “no medical use,” scientists have begun re-evaluating that dismissive assessment with the tools of modern science. Dozens of clinical trials of psychedelic-assisted therapies for depression, anxiety, post-traumatic stress disorder (PTSD) and other conditions are underway or planned. So far, the results […]
Jeff Neil, MD, PhD, was born and raised in Cleveland, Ohio. He attended St. Ignatius Jesuit High School; the same high school attended by Mike Noetzel, MD, former Director of Pediatric Neurology at St. Louis Children’s Hospital. Neil and Mike didn’t cross paths at school, as Mike played football and Neil played trombone, though Neil […]
Lisa Aten started working in the medical field over 30 years ago. She was initially in the retail business and was an area sales manager for Dillards Dept. stores. Even then, she loved working with people and helping them. The retail business demanded a lot of time, and she felt she needed to be home […]